12.02.2010 • NewsUnivarQuaronMergers & Acquisitions (M&A)

Univar To Acquire Quaron

Univar has signed an agreement to acquire the Quaron Group, a distributor of chemicals in Belgium, France and the Netherlands.

"We are pleased to announce an agreement to add the Quaron group to Univar," said Univar's CEO John Zillmer. "The combined organizations will provide Univar's supplier partners with greater opportunities for sales growth and technical service for their customers. For our customers, the acquisition offers better product selection and enhanced value-added services from our strong logistics platform."

The acquisition is subject to regulatory approval by the EU Commission.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.